Jiuzhou Pharmaceutical(SH:603456) Zheng Quan Zhi Xing·2025-07-29 16:21Core Viewpoint - The company, Zhejiang Jiuzhou Pharmaceutical Co., Ltd., has announced the establishment of special settlement accounts for cash management of idle raised funds, amounting to 785 million RMB, to enhance the efficiency of fund utilization and ensure the safety of the funds [1][9]. Group 1: Cash Management Overview - The cash management is entrusted to Industrial and Commercial Bank of China and Agricultural Bank of China [1]. - The cash management products include bank certificates of deposit with terms of 3 months, 6 months, and 12 months [1]. - The board of directors approved the use of up to 1.2 billion RMB of idle raised funds for cash management, ensuring it does not affect the construction and use of investment projects [1][9]. Group 2: Account Establishment - The company has opened sub-accounts for cash management at Agricultural Bank of China branches in Taizhou and Changshu [2]. - These accounts will be exclusively used for cash management of idle raised funds and will not be used for other purposes [4]. Group 3: Previous Cash Management Activities - Previously, the company used 21 million RMB of idle funds for cash management, which was redeemed by July 22, 2025, returning the principal and earnings to the special account [4]. Group 4: Purpose and Benefits of Cash Management - The purpose of cash management is to enhance fund efficiency while ensuring the safety of the raised funds and not impacting ongoing investment projects [5][10]. - The income generated from cash management will belong to the company and will be returned to the special account upon maturity [9]. Group 5: Regulatory Compliance - The cash management activities comply with relevant regulations from the China Securities Regulatory Commission and the Shanghai Stock Exchange [4][10]. - The company has received consent from its sponsor for the cash management activities [10].